Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound

Companies flush with cash are looking for good investments and innovative products that can reduce procedure costs, industry observers say.

By Peter Green • Jan. 31, 2023

FDA device center’s 2022 report reveals 37% drop in annual breakthrough designations

The annual report also highlighted the CDRH’s work on pulse oximeters, Philips’ recall of sleep and respiratory devices, cybersecurity and artificial intelligence.

By Nick Paul Taylor • Jan. 31, 2023

Explore the Trendline➔

Top 5 stories from MedTech Dive

From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.

By MedTech Dive staff

Medtronic recalls 22,000 hemodialysis catheters for potential hub defect

The FDA reported two injuries tied to the problem, which could cause leaks across the tubes of the implanted catheters and produce blood clots.

By Susan Kelly • Jan. 30, 2023

LivaNova recalls circulatory support device for software fix

The update is intended to fix a malfunction that could cause its LifeSPARC pump to stop working. 

By Elise Reuter • Jan. 30, 2023

GE HealthCare posts revenue growth in last quarter before spinoff on imaging, ultrasound units

The company benefitted from “robust end-market demand, improved pricing, and easing supply chain pressures” in the period.

By Peter Green • Jan. 30, 2023

Philips will cut 6,000 more jobs to reduce costs after company swung to net loss in Q4

New CEO Roy Jakobs said Philips has been spreading its resources too thinly and “can't and won't be selling everything everywhere anymore.”

By Nick Paul Taylor • Jan. 30, 2023

Friday Q&A: Tandem’s chief strategy officer talks tubeless pumps, Type 2 plans

Elizabeth Gasser also discusses the company’s recent acquisition of AMF Medical as well as how it factors environmental impact into device design.

By Elise Reuter • Jan. 27, 2023

ResMed quarterly revenue beats estimates as supply chain woes ease

Demand for CPAP devices and respirators remains strong as the company expects to pick up additional market share from rival Philips, and demand grows for its medical SaaS products.

By Susan Kelly • Jan. 27, 2023

Medtronic wearable partner files for bankruptcy but plans to continue ‘without interruption’

Rockley Photonics works with two of the top five medtech companies, plus six leading smart watch makers including Apple, but has run into financial problems.

By Nick Paul Taylor • Jan. 27, 2023

Why medical device designers need to become more agile — and how they can do it

To stay competitive, medtech firms must center manufacturing in business optimization plans, while embracing a design-to-value approach, says Jennifer Samproni, Flex’s chief technology officer for its Health Solutions division.

By Jennifer Samproni • Jan. 26, 2023

Medtech regulation outlook in 2023: Faster approvals among priorities as AI moves to fore

Leaders in the medtech field weigh in on the prospects and challenges for product regulation in 2023.

By Peter Green • Updated Jan. 26, 2023

Researchers create remote-controlled biological robot that could eventually be used in surgery

The design allows the integration of sensors and other components that could eventually equip the robots to detect biomarkers of disease, carry out biopsies or perform surgery.

By Nick Paul Taylor • Jan. 26, 2023

Getinge heart pump gets third Class I recall after patient death

Customers were alerted to problems with Cardiosave devices late last year after Getinge received complaints about an issue linked to four serious injuries and one death.

By Nick Paul Taylor • Jan. 26, 2023

Abbott sees ‘signs of stability’ for 2023 as hospital staffing, supply chain improves

While the company continues to grapple with supply shortages and procedure restrictions, it sold more COVID-19 tests than expected in the fourth quarter.

By Elise Reuter • Jan. 25, 2023

Cybersecurity ‘more critical than ever’ in era of connected care: BD

The device maker’s annual report on the state of healthcare cybersecurity calls for better transparency and coordination across the industry.

By Susan Kelly • Jan. 25, 2023

Intuitive Q4 profit slips on costs to boost share of robotic surgery market

The investment in innovation comes as Intuitive tries to maintain its dominant position in the face of rivals including Johnson & Johnson and Medtronic.

By Nick Paul Taylor • Jan. 25, 2023

3M’s healthcare unit Q4 earnings drop on nurse shortages, falling hospital budgets

Elective healthcare procedure volumes were about 90% of pre-COVID levels.

By Nick Paul Taylor • Jan. 25, 2023

J&J sees Abiomed adding to revenue in 2024; Q4 sales drop

Foreign-exchange fluctuations helped curb revenue in the period.

By Peter Green • Jan. 24, 2023

Insulet reports personal-data leak of 29,000 insulin pump customers

In a recall communication to users, Insulet shared information with its website performance and marketing partners through cookies and other trackers embedded in its website. 

By Nick Paul Taylor • Jan. 24, 2023

Medtronic asks HVAD users to return batteries with welding defects

The recall is one of several related to battery issues after the heart pump was pulled from the market.

By Elise Reuter • Jan. 23, 2023

3 questions for Michael Snyder, lead inventor of single-drop blood test

The head of a Stanford research team says the test differs from Theranos' defunct product because "ours works."

By Peter Green • Jan. 23, 2023

Ethylene oxide regulation may disrupt device supply, AdvaMed warns White House

The trade group has asked President Joe Biden to consider the potential threat to patient care if facilities are shut down.

By Nick Paul Taylor • Jan. 23, 2023

FDA demands additional data on Abbott rival to Medtronic balloon, setting back approval timeline

Abbott’s partner Surmodics is “evaluating options” to reduce its spending while preparing a response to the regulator’s requests.

By Nick Paul Taylor • Jan. 20, 2023

Dexcom CEO discusses 2023 plans, expanding to more patients with Type 2 diabetes

MedTech Dive caught up with Kevin Sayer for a conversation about forthcoming product launches and long-term plans to expand CGMs to a broader group of patients. 

By Elise Reuter • Updated Jan. 20, 2023

Medtech hazards: Problems with Philips’ recall put safety of home-use devices at top of danger list

Patient safety group ECRI is challenging manufacturers to provide easy-to-follow device registration instructions and write simply worded recall notices.

By Nick Paul Taylor • Jan. 19, 2023